Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment

CC BY 4.0 · Indian J Med Paediatr Oncol 2024; 45(04): 320-322

DOI: DOI: 10.1055/s-0044-1786017

READ MORE PDF

Bortezomib

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2010; 31(04): 143-144

DOI: DOI: 10.4103/0971-5851.76199

READ MORE PDF

Trastuzumab Deruxtecan: A Quantum Leap in HER2?Positive Breast Cancer

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(04): 556-558

DOI: DOI: 10.4103/ijmpo.ijmpo_264_19

READ MORE PDF

High-dose Methotrexate

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(03): 424-426

DOI: DOI: 10.4103/ijmpo.ijmpo_157_19

READ MORE PDF

Olanzapine: The Game-Changer “Antiemetic”

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(02): 274-276

DOI: DOI: 10.4103/ijmpo.ijmpo_151_19

READ MORE PDF

Venetoclax – The Game-changer in Hematology

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 555-558

DOI: DOI: 10.4103/ijmpo.ijmpo_260_20

READ MORE PDF

Ivosidenib – Another Feather in the Hat of Treatment for Acute Myeloid Leukemia

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 552-554

DOI: DOI: 10.4103/ijmpo.ijmpo_81_20

READ MORE PDF

Pembrolizumab: The Nut Cracker

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(03): 393-396

DOI: DOI: 10.4103/ijmpo.ijmpo_37_20

READ MORE PDF

Drug Review: Ibrutinib

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(03): 383-392

DOI: DOI: 10.4103/ijmpo.ijmpo_36_20

READ MORE PDF

Drug review: Fosaprepitant

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(01): 132-135

DOI: DOI: 10.4103/ijmpo.ijmpo_57_19

READ MORE PDF

Drug review: Carfilzomib

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(01): 130-131

DOI: DOI: 10.4103/ijmpo.ijmpo_67_19

READ MORE PDF

Taxanes – The Backbone of Medical Oncology

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 221-234

DOI: DOI: 10.4103/ijmpo.ijmpo_1_20

READ MORE PDF

Ado-Trastuzumab Emtansine – The Monoclonal Drug Conjugate in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(02): 218-220

DOI: DOI: 10.4103/ijmpo.ijmpo_246_19

READ MORE PDF

Daratumumab

CC BY-NC-ND 4.0 ? Indian J Med Paediatr Oncol 2020; 41(01): 57-60

DOI: DOI: 10.4103/ijmpo.ijmpo_263_19

READ MORE PDF

Trastuzumab: A Milestone in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

CC BY-NC-ND 4.0 ? Indian J Med Paediatr Oncol 2020; 41(01): 54-56

DOI: DOI: 10.4103/ijmpo.ijmpo_252_19

READ MORE PDF


//